Some medical researchers and practitioners continue to question the use of statins to treat abnormal lipid levels in asymptomatic patients for the purpose of preventing cardiovascular disease. That reluctance leaves most cardiology researchers shaking their heads.
The latter cite the many studies showing benefits of statin therapy in the primary prevention setting, such as reduced risk for nonfatal myocardial infarction, nonfatal stroke, revascularization, and cardiovascular death. They also suggest, although the evidence is not as robust, that statin therapy in asymptomatic individuals may reduce all-cause mortality risk.
Mitka M. Statin Therapy in Primary CVD Prevention Remains a Hot-button Topic for Some. JAMA. 2011;306(19):2077–2078. doi:10.1001/jama.2011.1664
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: